Deerfield Management Company, L.P. (Series C) Collegium Pharmaceutical, Inc Transaction History
Deerfield Management Company, L.P. (Series C)
- $5.38 Billion
- Q3 2024
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 31,696 shares of COLL stock, worth $988,915. This represents 0.02% of its overall portfolio holdings.
Number of Shares
31,696
Previous 13,296
138.39%
Holding current value
$988,915
Previous $428,000
185.98%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding COLL
# of Institutions
247Shares Held
37.6MCall Options Held
100KPut Options Held
10K-
Black Rock Inc. New York, NY5.79MShares$181 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$82.2 Million1.79% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$73.2 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.14MShares$66.8 Million0.15% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$51.7 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.06B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...